What's in Biopharma Plasma LLC's pipeline?

Biopharma Plasma LLC has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Biopharma Plasma LLC's portfolio?

Top competitors by shared drug class: Baxalta now part of Shire, CSL Behring, Grifols Therapeutics LLC, Sir Takhtasinhji General Hospital, University of Edinburgh.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biopharma-plasma-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Biopharma Plasma LLC — Portfolio Competitive Intelligence Brief

Biopharma Plasma LLC pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
BP-SCIG 20%	BP-SCIG 20%	phase 3	Immunoglobulin replacement therapy	IgG (Immunoglobulin G)	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baxalta now part of Shire · 1 shared drug class
CSL Behring · 1 shared drug class
Grifols Therapeutics LLC · 1 shared drug class
Sir Takhtasinhji General Hospital · 1 shared drug class
University of Edinburgh · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Biopharma Plasma LLC:

Cite this brief

Drug Landscape (2026). Biopharma Plasma LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biopharma-plasma-llc. Accessed 2026-05-16.